Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell– and patient-derived tumor organoids

Abstract

There are few in vitro models of exocrine pancreas development and primary human pancreatic adenocarcinoma (PDAC). We establish three-dimensional culture conditions to induce the differentiation of human pluripotent stem cells (PSCs) into exocrine progenitor organoids that form ductal and acinar structures in culture and in vivo. Expression of mutant KRAS or TP53 in progenitor organoids induces mutation-specific phenotypes in culture and in vivo. Expression of TP53R175H induced cytosolic SOX9 localization. In patient tumors bearing TP53 mutations, SOX9 was cytoplasmic and associated with mortality. Culture conditions are also defined for clonal generation of tumor organoids from freshly resected PDAC. Tumor organoids maintain the differentiation status, histoarchitecture, phenotypic heterogeneity of the primary tumor, and retain patient-specific physiologic changes including hypoxia, oxygen consumption, epigenetic marks, and differential sensitivity to EZH2 inhibition. Thus, pancreatic progenitor organoids and tumor organoids can be used to model PDAC and for drug screening to identify precision therapy strategies.

Reliability of the Size Evaluation Method for Meningiomas: Maximum Diameter, ABC/2 Formula, and Planimetry Method

“…Among the CISS images that contained attachment with the dura mater, the maximum area and perimeter at the same slice were measured. FF was calculated as (4π × area)/perimeter 2 , where FF = 1 indicates a perfect circle and FF = 0 indicates a straight line (28).…”

Concepts to Target MYC in Pancreatic Cancer

“…However, testing of these findings in novel human cancer models reflecting the whole heterogeneity spectrum of the disease is necessary. Here, the recent development of human organoid PDAC models (82,83) will provide an appropriate platform to further develop MYC inhibitors and MYC-based therapeutic concepts in human disease models.…”

Development of bioluminescent chick chorioallantoic membrane (CAM) models from primary pancreatic cancer cells: A platform for drug testing

“…In an attempt to address some of these fundamental flaws, new methods using stem-cell based organoid models, tissue engineering or sophisticated 3D cell culture models have been established 30,31 . However, these methods are also quite complex and expensive and cannot replace systemic toxicity tests in living organisms.…”